title: Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
abstract: Melanocytic nevus rests in lymph nodes are a known diagnostic challenge, especially in patients with a history of melanoma. Reticulin and NM23 have been studied in this context. The pattern of reticulin staining in melanomas surrounds groups/nests of melanocytes but individual cells in benign nevi. NM23, a metastasis-suppressor gene, has an association with metastatic potential in melanomas and some carcinomas. Twenty-eight cases (14 cases of metastatic melanoma to lymph nodes and 14 cases of lymph node nevus rests, all confirmed with Melan-A staining) were stained with reticulin and NM23. The pattern of reticulin staining was reported as surrounding groups if staining was noted in approximately 5-10 melanocytes in greater than 50% of the lesion but was otherwise reported as surrounding individual melanocytes. Cytoplasmic staining was considered to represent reactivity for NM23. Reticulin staining around groups of melanocytes was identified in all 14 cases of metastatic melanoma. Regarding nodal nevus rest cases, 12 of 14 cases (86%) demonstrated staining around individual melanocytes, whereas in 2 cases, reticulin surrounded melanocytic groups. NM23 staining was equivocal in all cases. Reticulin staining reliably invests groups of melanocytes in cases of metastatic melanoma, whereas in nodal nevus rests, it predominantly surrounds individual melanocytes. NM23 demonstrated no discriminatory value in this analysis. In cases in which a collection of melanocytes is present within a lymph node, reticulin deposition around individual melanocytes supports a diagnosis of lymph nodal nevus rest.
authors.affiliation: Department of Pathology, University of Virginia Health System, Charlottesville, VA 22908-0214, USA. kannerw@gmail.com
authors.forename: William A
authors.initials: WA
authors.lastname: Kanner
authors.forename: Catherine I
authors.initials: CI
authors.lastname: Barry
authors.forename: Chandra N
authors.initials: CN
authors.lastname: Smart
authors.forename: David P
authors.initials: DP
authors.lastname: Frishberg
authors.forename: Scott W
authors.initials: SW
authors.lastname: Binder
authors.forename: Mark R
authors.initials: MR
authors.lastname: Wick
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D001706:Biopsy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000737:chemistry* / Q000473:pathology; D008207:Lymphatic Metastasis; D058965:MART-1 Antigen / Q000032:analysis; D008297:Male; D008544:Melanocytes / Q000737:chemistry* / Q000473:pathology; D008545:Melanoma / Q000737:chemistry* / Q000556:secondary; D054778:NM23 Nucleoside Diphosphate Kinases / Q000032:analysis*; D009508:Nevus, Pigmented / Q000737:chemistry* / Q000473:pathology; D012155:Reticulin / Q000032:analysis*; D012878:Skin Neoplasms / Q000737:chemistry* / Q000473:pathology; D014481:United States
chemical_list: D014408:Biomarkers, Tumor; D058965:MART-1 Antigen; C548667:MLANA protein, human; D054778:NM23 Nucleoside Diphosphate Kinases; D012155:Reticulin; C517938:NME1 protein, human